Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -724.44M | 833.22M | 754.13M | -673.22M | |
| Total Depreciation and Amortization | -3.14M | 203.97M | 2.03M | -2.77M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 1.90B | -996.17M | -46.39M | -245.97M | |
| Change in Net Operating Assets | -376.78M | 796.72M | -227.72M | 1.75B | |
| Cash from Operations | 797.53M | 837.74M | 482.05M | 826.74M | |
| Capital Expenditure | -53.55M | -112.72M | -67.65M | -185.72M | |
| Sale of Property, Plant, and Equipment | -376.60K | 1.45M | -488.20K | 50.94M | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -886.61M | -938.12M | 705.01M | -187.74M | |
| Cash from Investing | -940.53M | -1.05B | 636.86M | -322.53M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 2.51B | 5.93B | -1.98B | 2.03B | |
| Issuance of Common Stock | 0.00 | 12.00M | 4.00M | 11.00M | |
| Repurchase of Common Stock | -3.93B | -3.00M | -1.00M | -1.00M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -1.39B | -3.03M | |
| Other Financing Activities | -4.94B | -8.32B | -121.00M | -4.07B | |
| Cash from Financing | -39.48M | -14.63M | -1.41B | -17.07M | |
| Foreign Exchange rate Adjustments | 9.59M | 32.71M | 14.40M | 22.92M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -172.89M | -193.56M | -275.69M | 510.06M | |